About us
Overview
Management team
Board of directors
Collaborations
Contact us
Tiltan’s drug combination
Tiltan's technology
Scientific rationale
TL-118
Mode of Action
Intellectual Property (IP)
Competitive advantages
Clinical trials
Clinical overview
TLH-206
Previous clinical trials
Clinical case reports
Research & Development
Preclinical studies
Preclinical collaborations
Scientific publications
Press Release
Submitting Form...
The server encountered an error.
Form received.
2.4 Hi tech Village,
Edmond Safra campus,
Givat Ram P.O.B 39026,
Jerusalem 91390 Israel
Phone: +972-2-5669411
Email: info@tiltanpharma.com
Built by Badboy.co.il
© copyright 2015 Tiltan Pharma